Purchiaroni F - Search Results

1

The role of intestinal microbiota and the immune system.

Purchiaroni F, Tortora A, Gabrielli M, Bertucci F, Gigante G, Ianiro G, Ojetti V, Scarpellini E, Gasbarrini A. Purchiaroni F, et al. Eur Rev Med Pharmacol Sci. 2013 Feb;17(3):323-33. Eur Rev Med Pharmacol Sci. 2013. PMID: 23426535 Free article. Review.

2

Colitides.

Tortora A, Purchiaroni F, Scarpellini E, Ojetti V, Gabrielli M, Vitale G, Giovanni G, Gasbarrini A. Tortora A, et al. Among authors: purchiaroni f. Eur Rev Med Pharmacol Sci. 2012 Nov;16(13):1795-805. Eur Rev Med Pharmacol Sci. 2012. PMID: 23208963 Free article. Review.

3

Gut microbiota and obesity.

Scarpellini E, Campanale M, Leone D, Purchiaroni F, Vitale G, Lauritano EC, Gasbarrini A. Scarpellini E, et al. Among authors: purchiaroni f. Intern Emerg Med. 2010 Oct;5 Suppl 1:S53-6. doi: 10.1007/s11739-010-0450-1. Intern Emerg Med. 2010. PMID: 20865475 Review.

4

Role of gut microbiota in food tolerance and allergies.

Gigante G, Tortora A, Ianiro G, Ojetti V, Purchiaroni F, Campanale M, Cesario V, Scarpellini E, Gasbarrini A. Gigante G, et al. Among authors: purchiaroni f. Dig Dis. 2011;29(6):540-9. doi: 10.1159/000332977. Epub 2011 Dec 12. Dig Dis. 2011. PMID: 22179209 Review.

5

The metabolic and toxicological considerations for mTOR inhibitors in the treatment of hepatocarcinoma.

Ponziani F, Ojetti V, Tortora A, Di Maurizio L, Purchiaroni F, Gasbarrini A. Ponziani F, et al. Among authors: purchiaroni f. Expert Opin Drug Metab Toxicol. 2011 Dec;7(12):1535-46. doi: 10.1517/17425255.2011.631911. Epub 2011 Oct 27. Expert Opin Drug Metab Toxicol. 2011. PMID: 22032293 Review.

6

Effect of beta-glucan, inositol and digestive enzymes in GI symptoms of patients with IBS.

Ciacci C, Franceschi F, Purchiaroni F, Capone P, Buccelletti F, Iacomini P, Ranaudo A, Andreozzi P, Tondi P, Gentiloni Silveri N, Gasbarrini A, Gasbarrini G. Ciacci C, et al. Among authors: purchiaroni f. Eur Rev Med Pharmacol Sci. 2011 Jun;15(6):637-43. Eur Rev Med Pharmacol Sci. 2011. PMID: 21796867 Clinical Trial.

7

Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.

Gasbarrini A, Scarpellini E, Gabrielli M, Tortora A, Purchiaroni F, Ojetti V. Gasbarrini A, et al. Among authors: purchiaroni f. Aliment Pharmacol Ther. 2011 Jun;33(12):1378-9; author reply 1379-80. doi: 10.1111/j.1365-2036.2011.04657.x. Aliment Pharmacol Ther. 2011. PMID: 21569063 No abstract available.

8

Glioblastoma multiforme and hepatitis B: do the right thing(s).

Purchiaroni F, Begini P, Minniti G, Gallina S, Delle Fave G, Marignani M. Purchiaroni F, et al. Eur Rev Med Pharmacol Sci. 2014;18(23):3629-31. Eur Rev Med Pharmacol Sci. 2014. PMID: 25535132 Free article.

9

Metformin plus proton pump inhibitors therapy: the cobalamin deficiency challenge.

Purchiaroni F, Galli G, Annibale B. Purchiaroni F, et al. Eur Rev Med Pharmacol Sci. 2015 Jul;19(13):2501-2. Eur Rev Med Pharmacol Sci. 2015. PMID: 26214788 Free article.

10

Acute fulminant hepatitis E virus genotype 3e infection: description of the first case in Europe.

Festa S, Garbuglia AR, Baccini F, Panzuto F, Capobianchi MR, Santino I, Purchiaroni F, Orgera G, Delle Fave G, Marignani M. Festa S, et al. Among authors: purchiaroni f. Scand J Infect Dis. 2014 Oct;46(10):727-31. doi: 10.3109/00365548.2014.928417. Epub 2014 Aug 19. Scand J Infect Dis. 2014. PMID: 25134653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters